SjöGren's Syndrome New Treatment 2025. Investigational therapy dazodalibep significantly eased symptom burden in people with sjögren’s syndrome. Ss is defined as primary (p).
Here, the authors combine data from a large cohort of patients and healthy controls to identify biomarkers that. Investigational therapy dazodalibep significantly eased symptom burden in people with sjögren’s syndrome.
Sjögren’s syndrome (ss) is a chronic autoimmune disorder whose typical manifestations are oral and ocular dryness.
Primary ss is a chronic, autoimmune condition characterized by lymphocytic infiltration of the exocrine glands, which leads to glandular dysfunction.
Investigational therapy dazodalibep significantly eased symptom burden in people with sjögren’s syndrome.
Sjögren's syndrome is a heterogeneous autoimmune condition that impairs quality of life because of dryness, fatigue, pain, and systemic involvements.